Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin J Abrahamson

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Archives of Internal Medicine|March 10, 2004
Optimal glycemic control in type 2 diabetes mellitus: fasting and postprandial glucose in contextMartin J Abrahamson
The American Journal of Medicine|December 18, 2003
Clinical use of thiazolidinediones: recommendationsMartin J Abrahamson
Primary Care Diabetes|April 17, 2010
Basal insulins: Pharmacological properties and patient perspectivesMartin J Abrahamson
JAMA|January 11, 2007
A 74-year-old woman with diabetesMartin J Abrahamson
Diabetes Care|December 25, 2014
Should sulfonylureas remain an acceptable first-line add-on to metformin therapy in patients with type 2 diabetes? Yes, they continue to serve us well!Martin J Abrahamson
Diabetes Technology & Therapeutics|May 1, 2004
Durability of glycemic control: a feature of the thiazolidinedionesShanti Serdy, Martin J Abrahamson
Annals of Medicine|July 25, 2012
Intensification of insulin therapy in patients with type 2 diabetes mellitus: an algorithm for basal-bolus therapyMartin J Abrahamson, Anne Peters
The Journal of Family Practice|April 20, 2010
Insulin therapy for type 2 diabetes: making it workJody Dushay, Martin J Abrahamson
Mayo Clinic Proceedings|April 10, 2003
Pharmacological management of type 2 diabetes mellitus: rationale for rational use of insulinJean L Chan, Martin J Abrahamson
Journal of Women'S Health (2002)|January 15, 2005
Toward optimal health: the experts discuss important issues in hormone replacement and in diabetes. Interview by Jody R. GodfreyStacie E Geller, Martin J Abrahamson
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Archives of Internal Medicine|March 10, 2004
Optimal glycemic control in type 2 diabetes mellitus: fasting and postprandial glucose in contextMartin J Abrahamson
The American Journal of Medicine|December 18, 2003
Clinical use of thiazolidinediones: recommendationsMartin J Abrahamson
Primary Care Diabetes|April 17, 2010
Basal insulins: Pharmacological properties and patient perspectivesMartin J Abrahamson
JAMA|January 11, 2007
A 74-year-old woman with diabetesMartin J Abrahamson
Diabetes Care|December 25, 2014
Should sulfonylureas remain an acceptable first-line add-on to metformin therapy in patients with type 2 diabetes? Yes, they continue to serve us well!Martin J Abrahamson
Diabetes Technology & Therapeutics|May 1, 2004
Durability of glycemic control: a feature of the thiazolidinedionesShanti Serdy, Martin J Abrahamson
Annals of Medicine|July 25, 2012
Intensification of insulin therapy in patients with type 2 diabetes mellitus: an algorithm for basal-bolus therapyMartin J Abrahamson, Anne Peters
The Journal of Family Practice|April 20, 2010
Insulin therapy for type 2 diabetes: making it workJody Dushay, Martin J Abrahamson
Mayo Clinic Proceedings|April 10, 2003
Pharmacological management of type 2 diabetes mellitus: rationale for rational use of insulinJean L Chan, Martin J Abrahamson
Journal of Women'S Health (2002)|January 15, 2005
Toward optimal health: the experts discuss important issues in hormone replacement and in diabetes. Interview by Jody R. GodfreyStacie E Geller, Martin J Abrahamson
Pageof 4